GKWIM
EDIT icon

Gerber Kawasaki Wealth & Investment Management’s Editas Medicine EDIT Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,580
Closed -$105K – 512
2021
Q3 		$105K Buy
+2,580
New +$141K 0.01% 234
2018
Q3 		– Sell
-6,205
Closed -$229K – 122
2018
Q2 		$229K Hold
6,205
– – 0.07% 96
2018
Q1 		$205K Buy
+6,205
New +$221K 0.07% 108

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's EDIT Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 2,580 shares — an estimated $105K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in EDIT in Q1 2018 and held it in 3 quarters. The position peaked at $229K in Q2 2018. 306 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 2,580 Editas Medicine shares in Q4 2021, an estimated $105K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Editas Medicine in Q1 2018 and held it in 3 quarters.
  • Gerber Kawasaki Wealth & Investment Management's Editas Medicine position peaked at $229K in Q2 2018.
  • 306 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.